Dr. Antonios Douros received his Medical degree in 2009 and his Doctorate degree (Dr. med.) in 2012, and was trained in Clinical Pharmacology from 2012 to 2016 at Charité – Universitätsmedizin Berlin in Berlin, Germany. He completed a post-doctoral fellowship in Pharmacoepidemiology from 2016 to 2018 at the Department of Epidemiology, Biostatistics and Occupational Health at McGill University in Montreal, Canada. He then joined the McGill Department of Medicine as an Assistant Professor in 2019. Dr. Douros studies the effectiveness and safety of medications in vulnerable populations, including patients with liver disease, older adults, as well as patients subjected to polypharmacy and at risk of drug-drug interactions. Dr. Douros applies his experience with observational studies using large electronic healthcare databases from Canada, the United Kingdom, and Germany, and his knowledge on the distinct pharmacologic features of vulnerable populations. He has (co-)authored >60 peer-reviewed publications including several in high-impact journals such as the British Medical Journal, Annals of Internal Medicine, European Heart Journal, Journal of the American College of Cardiology, and Diabetes Care. His research is supported by awards and grants from the German Research Foundation, the Canadian Institutes of Health Research, and the Fonds de recherche du Québec – Santé.

Shopping Basket